Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).

  • FEAnalytics.com
  • FEInvest.net
  • FETransmission.com
  • Investegate.co.uk
  • Trustnet.hk
  • Trustnetoffshore.com
  • Trustnetmiddleeast.com

For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.

WHAT INFORMATION DO WE COLLECT ABOUT YOU?

We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.

COOKIES

In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.

HOW WE USE INFORMATION

We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.

ACCESS TO YOUR INFORMATION AND CORRECTION

We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.

WHERE WE STORE YOUR PERSONAL DATA

The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.

CHANGES TO OUR PRIVACY POLICY

Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.

OTHER WEBSITES

Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.

CONTACT

If you want more information or have any questions or comments relating to our privacy policy please email publishing@financialexpress.net in the first instance.

 Information  X 
Enter a valid email address

Collagen Sol PLC (COS)

  Print      Mail a friend

Monday 20 March, 2017

Collagen Sol PLC

Introduces new online sales initiative in the US

RNS Number : 9228Z
Collagen Solutions PLC
20 March 2017
 

Collagen Solutions Plc

(the "Company" or the "Group")

 

Collagen Solutions introduces new online sales initiative in the US

 

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, has launched a new B to C web-based business in the US to sell standard collagen products directly to end users in the research market.

 

This is an important initiative for the company as it directly connects Collagen Solutions with end users in a cost effective manner while simultaneously addressing the purchasing needs of researchers.  Further, understanding the evolving requirements of this customer segment will help to ensure that the company is supplying the right products for the right markets. From the point of view of the end user, having easy access to medical grade collagen from the outset will help the transition from a research project to a full blown medical device.

 

Commenting on the new online store, Jamal Rushdy, CEO of Collagen Solutions said: "This initiative serves three purposes for Collagen Solutions. First, it increases our access to the estimated US$200m global market for cell culture reagents. Secondly, it gives us a direct link with the end users of our products so that we can understand their needs and how the market for collagen is evolving. Finally, it establishes Collagen Solutions as the go-to collagen supplier among investigators whose research will guide the rapidly advancing world of regenerative medicine."

 

About Collagen Solutions:  

Collagen Solutions Plc is a global supplier, developer, and manufacturer of medical grade collagen, tissues, and related medical devices and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The Company is also expanding its range of biomaterials-based finished medical devices based on its internal and acquired intellectual property for commercialisation with partners via licensing and distribution arrangements, including ChondroMimetic, an osteochondral scaffold for repairing cartilage defects in the knee. The Company's products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology.

 

For additional information on the benefits of Collagen Solutions products for research, please visit:

https://www.researchgate.net/institution/Collagen_Solutions/post/5899edb93d7f4b8dfc79d560_Ultra-Pure_Collagen_Biomaterials_to_Progress_Your_Research 

 

 

As a reminder, Jamal Rushdy, CEO of collagen Solutions will be hosting an investor event today, Monday 20 March, commencing at 4.30 at the Rocket Bar, 6 Adams Court, Old Broad Street, EC2N 1DX.  After a formal presentation on the prospects for the Company going forward, Jamal will be available to answer individual questions over refreshments.  If you have not already informed us and would like to attend, please contact: collagen@walbrookpr.com to reserve a place.

 

 



 

Enquiries: 

 

 

Collagen Solutions Plc

Contact via Walbrook

Jamal Rushdy, Chief Executive Officer  

 

Gill Black, Chief Financial Officer

 

 

 

Cenkos Securities plc (Nominated Adviser and Broker)

Stephen Keys

Steve Cox   

Tel: 0207 397 8900

 

 

 

 

Walbrook PR

    Tel: 020 7933 8780 or collagen@walbrookpr.com

Mike Wort

Mob: 07900 608 002

Anna Dunphy

Mob: 07876 741 001

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALIFSTVDIIFID

a d v e r t i s e m e n t